jueves, 30 de diciembre de 2010

National Guideline Clearinghouse | The continued use of trastuzumab beyond disease progression in patients with metastatic breast cancer.


Guideline Title
The continued use of trastuzumab beyond disease progression in patients with metastatic breast cancer.

Bibliographic Source(s)
Madarnas Y, Haynes AE, Eisen A. The continued use of trastuzumab beyond disease progression in patients with metastatic breast cancer. Toronto (ON): Cancer Care Ontario (CCO); 2009 Aug 17. 26 p. (CED-CCO special advice report; no. 13). [21 references]


Guideline Status

This is the current release of the guideline.

Please visit the Cancer Care Ontario Web site [http://www.cancercare.on.ca/common/pages/UserFile.aspx?fileId=58587] External Web Site Policy for details on any new evidence that has emerged and implications to the guidelines

full-text:
National Guideline Clearinghouse | The continued use of trastuzumab beyond disease progression in patients with metastatic breast cancer.

No hay comentarios:

Publicar un comentario